author-photo

Stefano Mazza

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

19

Papers

128

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases.

2021 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (0)
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study.

2021 Clinical and Translational Science
Show All
- Source
- Cite
- Save
Citations (0)
Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy.

2020 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (12)
Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak.

2020 Inflammatory Bowel Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Probiotic Lactobacillus and Bifidobacterium Strains Counteract Adherent-Invasive Escherichia coli (AIEC) Virulence and Hamper IL-23/Th17 Axis in Ulcerative Colitis, but Not in Crohn's Disease.

2020 Cells
Show All
- Source
- Cite
- Save
Citations (9)
Immunological variables associated with clinical and endoscopic response to vedolizumab in patients with inflammatory bowel diseases

2020 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (5)
Focus on Very Late Hepatocellular Carcinoma Recurring After Liver Transplantation: A Case Report and Literature Review

2019 Transplantation Proceedings
Show All
- Source
- Cite
- Save
Citations (1)
Previous colonic resection is a risk factor for surgical relapse in Crohn’s disease

2019 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (2)
EXPERIENCE WITH EARLY SORAFENIB TREATMENT WITH mTOR INHIBITORS IN HEPATOCELLULAR CARCINOMA RECURRING AFTER LIVER TRANSPLANTATION

2019 Transplantation
Show All
- Source
- Cite
- Save
Citations (13)
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study

2019 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (7)